NT-proBNP level before primary PCI and risk of poor myocardial reperfusion: Insight from the On-TIME II trial-Reference-Cited by-同舟云学术

NT-proBNP level before primary PCI and risk of poor myocardial reperfusion: Insight from the On-TIME II trial

Published:2021-03 Issue: Volume:233 Page:78-85
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Fabris Enrico,ten Berg Jurrien M.,Hermanides Renicus S.,Ottervanger Jan Paul,Dambrink Jan Henk E,Gosselink AT Marcel,Sinagra Gianfranco,Koopmans Petra C.,Giannitsis Evangelos,Hamm Christian,van ’t Hof Arnoud W.J.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference31 articles.

1. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

2. Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, double-blind, randomised controlled trial;Van't Hof;Lancet,2008

3. Vigorous response in plasma N-terminal pro-brain natriuretic peptide (NT-BNP) to acute myocardial infarction;Gill;Clin Sci (Lond),2004

4. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes;de Lemos;N Engl J Med,2001

5. N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes;Heeschen;Circulation,2004

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Early Heparin Anticoagulation on Blood Flow and Cardiac Function in Patients with Acute ST Segment Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention;The Heart Surgery Forum;2024-06-16

2. FT3/FT4 Enhances Risk Assessment in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention Based on GRACE 2.0 Score;Angiology;2023-10-24

3. Nt-Probnp in Patients with Acute Myocardial Infarction Without Heart Failure;Experimental and Applied Biomedical Research (EABR);2023-09-13

4. Association of N‐terminal pro‐B‐type natriuretic peptide with mortality in elderly (≥80 years) patients undergoing percutaneous coronary intervention;Catheterization and Cardiovascular Interventions;2022-08-30

5. Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide and High-Sensitivity C-Reactive Protein in Patients With Previous Myocardial Infarction;Frontiers in Cardiovascular Medicine;2022-02-24